Device Makers Want More Protections For Collecting Off-Label Data
This article was originally published in The Gray Sheet
Executive Summary
Government agencies should create a safe harbor where industry can collect post-market clinical data without fear of being perceived as promoting off-label use, industry speakers said at the Transcatheter Cardiovascular Therapeutics conference in San Francisco last month
You may also be interested in...
FDA Issues Guidance On Off-Label Info; Waxman Seeks ‘Re-examination’
Rep. Henry Waxman is calling for the Obama administration to re-examine a final FDA guidance that gives companies a way to distribute journal articles discussing off-label uses for approved medical devices and drugs
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.